Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate (23)
- Computing and Computational Sciences Directorate (35)
- Energy Science and Technology Directorate (217)
- Fusion and Fission Energy and Science Directorate
(21)
- Information Technology Services Directorate (2)
- Isotope Science and Enrichment Directorate (6)
- National Security Sciences Directorate (17)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (128)
- User Facilities (27)
Researcher
- Chad Steed
- Hongbin Sun
- Junghoon Chae
- Travis Humble
- Bruce Moyer
- Debjani Pal
- Ilias Belharouak
- Jeffrey Einkauf
- Jennifer M Pyles
- Justin Griswold
- Kuntal De
- Laetitia H Delmau
- Luke Sadergaski
- Mike Zach
- Padhraic L Mulligan
- Pradeep Ramuhalli
- Praveen Cheekatamarla
- Ruhul Amin
- Samudra Dasgupta
- Sandra Davern
- Vishaldeep Sharma

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

The invention presented here addresses key challenges associated with counterfeit refrigerants by ensuring safety, maintaining system performance, supporting environmental compliance, and mitigating health and legal risks.

The QVis Quantum Device Circuit Optimization Module gives users the ability to map a circuit to a specific quantum devices based on the device specifications.

QVis is a visual analytics tool that helps uncover temporal and multivariate variations in noise properties of quantum devices.

Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.

Knowing the state of charge of lithium-ion batteries, used to power applications from electric vehicles to medical diagnostic equipment, is critical for long-term battery operation.

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.

An ORNL team has developed a method for screening for an immunoregulatory protein, which includes assessing the sequence of a candidate protein to determine if it is an immunoregulatory protein when at least one plasminogen-apple-nematode (PAN) domain with a consensus sequence